Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2024 Filed May 23, 2024 23:16 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0000950170-24-064218 · ownership.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 22, 2024 Filed May 23, 2024 19:30 UTC |
CLARKE JOHN KDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0000950170-24-064235 · ownership.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 22, 2024 Filed May 23, 2024 23:19 UTC |
Lucas SvetlanaDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0000950170-24-064225 · ownership.xml · derivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 22, 2024 Filed May 23, 2024 23:07 UTC |
Coughlin TimothyDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0000950170-24-064199 · ownership.xml · derivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 01:18 UTC |
Broadfoot Jill MarieChief Financial Officer
|
SaleCommon stock | 1,590 | $1.69 | $2,687.10 |
DisclosureSEC source: 0001209191-24-002947 · doc4.xml · nonDerivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,821 F3 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. Read SEC document |
| February 05, 2024 Filed Feb 6, 2024 20:20 UTC |
Shukla SanjayDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002949 · doc4.xml · derivative · entry 2 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,750 Underlying: Common Stock · 10,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 05, 2024 Filed Feb 6, 2024 20:20 UTC |
Shukla SanjayDirector · President and CEO
|
Exercise / conversionCommon stock | 10,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002949 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 01:18 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002947 · doc4.xml · derivative · entry 3 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 01:18 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionCommon stock | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002947 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 01:15 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002945 · doc4.xml · derivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,374 Underlying: Common Stock · 2,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 01:15 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionCommon stock | 2,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002945 · doc4.xml · nonDerivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 19:35 UTC |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 600,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-24-001302 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2034-01-05 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 00:33 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-24-001299 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-01-05 F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 00:30 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-24-001297 · doc4.xml · derivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-01-05 F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| December 12, 2023 Filed Dec 12, 2023 18:50 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 12,000 | $1.18 | $14,136.00 |
DisclosureSEC source: 0001209191-23-058377 · doc4.xml · nonDerivative · entry 2 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,173 F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 11, 2023 Filed Dec 12, 2023 18:50 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 3,000 | $1.17 | $3,510.00 |
DisclosureSEC source: 0001209191-23-058377 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,173 Read SEC document |
| November 13, 2023 Filed Nov 13, 2023 16:11 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 13,578 | $1.11 | $15,085.16 |
DisclosureSEC source: 0001209191-23-054976 · doc4.xml · nonDerivative · entry 2 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,173 F2 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.09 to $1.13 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 16:11 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 1,422 | $1.14 | $1,618.24 |
DisclosureSEC source: 0001209191-23-054976 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,595 F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.13 to $1.14 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:07 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 15,000 | $2.01 | $30,223.50 |
DisclosureSEC source: 0001209191-23-043943 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,173 F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.01 to $2.02 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:29 UTC |
Gross Jane ADirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-23-031012 · doc4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:33 UTC |
Zaknoen SaraDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-23-031024 · doc4.xml · derivative · entry 1 Zaknoen Sara · CIK 0001602225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:32 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-23-031020 · doc4.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 16:23 UTC |
CLARKE JOHN KDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-23-031002 · doc4.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:27 UTC |
Coughlin TimothyDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-23-031008 · doc4.xml · derivative · entry 3 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-05-17 F2 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:27 UTC |
Coughlin TimothyDirector
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031008 · doc4.xml · nonDerivative · entry 2 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,000 F1 · ownership.nature: These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:27 UTC |
Coughlin TimothyDirector
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031008 · doc4.xml · nonDerivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:30 UTC |
Lucas SvetlanaDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-23-031016 · doc4.xml · derivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 10, 2023 Filed May 11, 2023 13:00 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 200,000 | $2.25 | $450,000.00 |
DisclosureSEC source: 0001209191-23-028607 · doc4.xml · nonDerivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 313,023 F1 · price: Represents weighted average price for the shares. The shares were purchased ranging from $2.245 to $2.25 per share under the issuer's "at-the-market" offering program implemented pursuant to the issuer's Open Market Sale Agreement with Jefferies LLC. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:52 UTC |
Gross Jane ADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026064 · doc4.xml · derivative · entry 2 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022. F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:52 UTC |
Gross Jane ADirector
|
Exercise / conversionCommon stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026064 · doc4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022. F2 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:56 UTC |
Zaknoen SaraDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026070 · doc4.xml · derivative · entry 2 Zaknoen Sara · CIK 0001602225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022. F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:56 UTC |
Zaknoen SaraDirector
|
Exercise / conversionCommon stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026070 · doc4.xml · nonDerivative · entry 1 Zaknoen Sara · CIK 0001602225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022. F2 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:54 UTC |
SCHIMMEL PAULDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026067 · doc4.xml · derivative · entry 4 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022. F5 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:54 UTC |
SCHIMMEL PAULDirector
|
Exercise / conversionCommon stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026067 · doc4.xml · nonDerivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022. F2 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 16:54 UTC |
CLARKE JOHN KDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026069 · doc4.xml · derivative · entry 2 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022. F4 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 16:54 UTC |
CLARKE JOHN KDirector
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026069 · doc4.xml · nonDerivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022. F2 · price: RSUs convert into common stock on a one-for-one basis. F3 · balance_after: Includes 6,305 shares received as a pro-rata distribution on September 28, 2021 (the "Liquidating Distribution") from CHP II, L.P., in which the Reporting Person is a managing partner. In prior reports, the reporting person reported beneficial ownership of 108,083 shares of aTyr Pharma common stock held by CHP II, L.P., which are no longer held as of September 28, 2021 due to the Liquidating Distribution. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:53 UTC |
Lucas SvetlanaDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026065 · doc4.xml · derivative · entry 2 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022. F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:53 UTC |
Lucas SvetlanaDirector
|
Exercise / conversionCommon stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026065 · doc4.xml · nonDerivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022. F2 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:51 UTC |
Coughlin TimothyDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026062 · doc4.xml · derivative · entry 2 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022. F3 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:51 UTC |
Coughlin TimothyDirector
|
Exercise / conversionCommon stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026062 · doc4.xml · nonDerivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022. F2 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 17:08 UTC |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 336,096 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-23-011282 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,096 Underlying: Common Stock · 336,096 shares Expires 2033-02-16 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:04 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 84,023 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-23-011275 · doc4.xml · derivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,023 Underlying: Common Stock · 84,023 shares Expires 2033-02-16 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:00 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 84,023 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-23-011248 · doc4.xml · derivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,023 Underlying: Common Stock · 84,023 shares Expires 2033-02-16 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 00:00 UTC |
Broadfoot Jill MarieChief Financial Officer
|
SaleCommon stock | 1,566 | $2.36 | $3,695.76 |
DisclosureSEC source: 0001209191-23-007364 · doc4.xml · nonDerivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,460 F4 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 3, 2022. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 18:57 UTC |
Shukla SanjayDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007362 · doc4.xml · derivative · entry 2 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,125 Underlying: Common Stock · 10,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 18:57 UTC |
Shukla SanjayDirector · President and CEO
|
Exercise / conversionCommon stock | 10,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-007362 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 00:00 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007364 · doc4.xml · derivative · entry 3 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F5 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 00:00 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionCommon stock | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-007364 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · balance_after: Includes 986 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 00:03 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007367 · doc4.xml · derivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,062 Underlying: Common Stock · 2,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 00:03 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionCommon stock | 2,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-007367 · doc4.xml · nonDerivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · balance_after: Includes 944 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 15, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.